F2 and polyarteritis nodosa: However, anti-phosphatidylserine-prothrombin complex (anti-PSPT) antibodies could be thought of as a biomarker for the existence of PAN and therefore could support making an early diagnosis in PAN patients with cutaneous manifestations.